The AHA joined by the Association of American Medical Colleges and America’s Essential Hospitals today will urge a federal court to prevent the Department of Health and Human Services from reducing Medicare payments under the 340B drug savings program by nearly 30% effective Jan. 1. In a brief to be filed today in reply to the agency’s motion to dismiss their lawsuit challenging the reduction, the hospital groups say the payment cut “far exceeds” HHS’s authority to adjust the reimbursement rate and warrants a preliminary injunction to prevent “imminent” and “actual” harm to their members. Thirty-two state and regional hospital associations also today will urge the court in a friend-of-the-court brief to grant the preliminary injunction, arguing that the estimated $1.6 billion cut “will have devastating consequences for safety-net providers and the millions of patients they serve.”

Related News Articles

Headline
The Department of Labor has issued a proposed rule to improve transparency of fees collected by pharmacy benefit managers. The rule requires PBMs to disclose…
Headline
The Department of Health and Human Services Office of Inspector General Jan. 27 released a bulletin addressing how direct-to-consumer drug programs can sell…
Headline
The Centers for Medicare & Medicaid Services Jan. 27 announced 15 drugs under Medicare Parts D and B selected for the third round of price negotiations.…
Headline
The AHA Jan. 26 urged the Health Resources and Services Administration to take immediate action to stop a new Eli Lilly and Company policy from taking effect…
Headline
The federal government has dropped its appeal of a preliminary injunction blocking implementation of the Department of Health and Human Services’ 340B Rebate…
Headline
The White House released a health care plan Jan. 15 addressing drug prices, health insurance premiums and price transparency efforts. The plan includes…